The UK Laboratory Filtration Market was valued at $203.3 Million in 2024 and projected to reach to $311.4 Million by 2029, representing a compound annual growth rate of 8.9%. The UK laboratory filtration market is poised for sustained expansion through 2029, supported by the nation's leading position in pharmaceutical innovation and clinical research.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
The UK laboratory filtration market is valued at $203.3 million in 2024, with strong growth trajectory driven by advanced healthcare infrastructure and robust pharmaceutical research capabilities.
The UK market is expanding at a CAGR of 8.9%, outpacing the global average of 8.3%, reflecting increased investment in clinical diagnostics and life sciences research across the nation.
Demand is fueled by the UK's world-leading pharmaceutical and biotechnology sectors, coupled with stringent regulatory standards requiring high-quality filtration solutions in clinical and research laboratories.
The market is projected to reach $311.4 million by 2029, representing a 53% increase over five years, driven by expanding diagnostic facilities and increased R&D spending in UK institutions.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | MEMBRANE FILTERS (Type) |
| Forecast Period | 2024–2029 |
| Growth Rate | CAGR of 8.3% from 2024 to 2029 |
| Largest Segment | FILTERS & FILTER MEDIA (Product) |
| Market Size Base Year (Billions) | ~USD 4.09 (2024) |
| Revenue Forecast (Billions) | ~USD 6.1 (2029) |
| Segments Covered | Product, Type, Material |
3 segment dimensions are covered across the global market.
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 28.3 | 30 | 32.1 | 34.6 | 37.4 | 40.5 | 44 | 47.8 | 8.3 |
| HOSPITALS & CLINICAL LABORATORIES | 13.3 | 14 | 14.8 | 15.8 | 16.9 | 18.2 | 19.5 | 21 | 7.2 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 135.5 | 144.8 | 156.3 | 169.7 | 185.1 | 202.2 | 221.2 | 242.6 | 9.2 |
| TOTAL | 177.1 | 188.7 | 203.3 | 220.1 | 239.5 | 260.9 | 284.7 | 311.4 | 8.9 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| ALLERGAN PLC | Ireland | Private Company | Medical aesthetics and dermatology,Eye care,Neuroscience and CNS, |
| TECHNICOLOR SA | France | Public Company | Broadband CPE (fiber gateways, routers, extenders, Wi-Fi XL, FWA including Falcon 5G),Video CPE (set-top boxes, dongles, smart media devices, media servers),Software, Platforms, and Service Management (navigate, HomeSight, service management solutions), |
| GENERAL ELECTRIC | United States | Public Company | Commercial Engines & OE Sales,Commercial MRO & Spare Parts,Defense & Propulsion OE, |
| GE HEALTHCARE | United States | Public Company | Imaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS), |
| MERCK KGAA | Germany | Public Company | Life Science (tools, reagents, bioprocessing, CDMO),Healthcare (oncology, neurology, fertility, rare diseases),Electronics (semiconductor and display materials, gases, equipment), |
| DANAHER CORPORATION | United States | Public Company | Biotechnology (bioprocessing and bioproduction solutions),Life Sciences (research tools, genomic and analytical systems),Diagnostics (clinical instruments, consumables, software, services), |
| SARTORIUS AG | Germany | Public Company | Bioprocess solutions (bioreactors, fermenters, filtration, process chromatography, fluid management),Lab products and services (lab filtration, water systems, weighing, pipettes, microbiological testing, OEM),Advanced analytical and cell-based solutions (BLI, cytometry, live-cell imaging, SPR, cell selection, microtissue), |
| THERMO FISHER SCIENTIFIC INC. | United States | Public Company | Life Sciences Solutions,Analytical Instruments,Specialty Diagnostics, |
| 3M COMPANY | United States | Public Company | Safety and Industrial,Transportation and Electronics,Consumer, |
| AGILENT TECHNOLOGIES, INC. | United States | Public Company | Life Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets, |
| EATON CORPORATION PLC | Ireland | Public Company | Electrical Americas,Electrical Global,Aerospace, |
| GEA GROUP | Germany | Public Company | Separation & Flow Technologies (separators, decanters, valves, pumps),Liquid & Power Technologies (brewing, liquid processing, thermal, carbon capture),Food & Health Technologies (meat, poultry, vegan, pharma processing), |
| AVANTOR, INC. | United States | Public Company | Materials and consumables,Equipment and instrumentation,Services and specialty procurements, |
| STERIS PLC | United States | Public Company | Healthcare (hospitals and providers),Applied Sterilization Technologies (contract sterilization),Life Sciences (pharma and biopharma solutions), |
| AHLSTROM | Finland | Private Company | Filtration and Life Sciences,Food and Consumer Packaging,Protective and Industrial Materials, |
| GVS S.P.A. | Italy | Public Company | Healthcare & Life Sciences Filtration,Health & Safety PPE and Industrial Filtration,Energy & Mobility Components, |
Allergan PLC is an Ireland-based private company founded in 1983 with 17,400 employees. The company operates in the pharmaceutical and specialty healthcare sectors.
Technicolor SA is a French public company established in 1985 with 1,552 employees. The company provides media and entertainment technology services.
General Electric is a United States-based public company founded in 1892 with 57,000 employees. The company operates across multiple industrial and technology sectors.
GE Healthcare is a United States-based public company founded in 2022 with 54,000 employees. The company provides healthcare technology and medical imaging solutions.
Merck KGaA is a German public company with roots dating back to 1668 and 59,077 employees. The company operates in pharmaceuticals, life sciences, and performance materials.
Danaher Corporation is a United States-based public company founded in 1969 with 59,000 employees. The company operates across diagnostics, life sciences, and environmental solutions.
Sartorius AG is a German public company founded in 1870 with 14,242 employees. The company specializes in laboratory and bioprocess technologies.
Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees. The company is a global leader in life sciences, analytical instruments, and laboratory services.
3M Company is a United States-based public company founded in 1902 with 60,500 employees. The company manufactures diversified products across industrial, healthcare, safety, and consumer segments.
Agilent Technologies, Inc. is a United States-based public company founded in 1999 with 18,000 employees. The company provides analytical instruments, software, and services for life sciences and diagnostics.
Eaton Corporation PLC is an Ireland-based public company founded in 1911 with 97,303 employees. The company operates in electrical, hydraulic, and industrial power management solutions.
GEA Group is a German public company founded in 1881 with 19,670 employees. The company provides process technology and equipment for the food, beverage, and pharmaceutical industries.
Avantor, Inc. is a United States-based public company founded in 1904 with 13,500 employees. The company supplies specialty chemicals, materials, and equipment for research and manufacturing.
Steris PLC is a United States-based public company founded in 1985 with 17,937 employees. The company provides sterilization, contamination control, and surgical support solutions.
Ahlstrom is a Finland-based private company founded in 1851 with 6,883 employees. The company produces fiber-based materials for various industrial applications.
GVS S.P.A. is an Italy-based public company founded in 1979 with 3,952 employees. The company manufactures filtration and separation products for healthcare and industrial markets.
The UK laboratory filtration market was valued at $203.3 million in 2024 and is expected to reach $311.4 million by 2029.
The UK laboratory filtration market is growing at a compound annual growth rate (CAGR) of 8.9% from 2024 to 2029.
Key drivers include rising laboratory testing volumes, expansion of biotechnology research, stringent regulatory standards, and increased focus on contamination control in UK healthcare facilities.
Primary consumers in the UK include clinical laboratories, pharmaceutical research institutions, diagnostic facilities, biotechnology companies, and public sector healthcare laboratories.
The UK market is a leading European hub for laboratory filtration, driven by advanced healthcare infrastructure, strong regulatory frameworks, and significant investment in life sciences research and precision medicine initiatives.
This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global laboratory filtration market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the laboratory filtration market. The secondary sources used for this study include International Association of Laboratory Schools (IALS), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), National Science Foundation (NSF), American Society for Clinical Laboratory Science (ASCLS), American Filtration and Separations Society (AFS), European Federation of Clinical Chemistry and Laboratory Medicine (EFLM), Canadian Association for Laboratory Accreditation (CALA), Canadian Society for Medical Laboratory Science (CSMLS), Food and Drug Administration (FDA), European Medicines Agency (EMA), Health Canada, National Institutes of Health (NIH), and World Health Organization (WHO), research journals; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Extensive primary research was conducted after acquiring basic knowledge about the global laboratory filtration market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical and biotechnology companies, CROs, CMOs, hospitals & clinical laboratories, and academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across six major regions, including the Asia Pacific, North America, Europe, Latin America, Middle East and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the laboratory filtration market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

To know about the assumptions considered for the study, Request for Free Sample Report
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Laboratory filtration refers to the separation of solid particles from liquids or gases using a filter medium in a controlled laboratory setting. Laboratory filtration products include filters & filter media, filtration assemblies, and filtration accessories used for laboratory-scale physical and chemical processes. This market includes laboratory filtration products that are utilized by pharmaceutical & biotechnology companies, academic & research institutes, and hospitals & clinical laboratories.
1 Micro markets are the further segments and subsegments of the laboratory filtration market included in the report
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Full forecast, segment splits, and company analysis for all Laboratory Filtration Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report